ArticleJournal of the American Medical Directors Association2026
Effectiveness of the PASRR Program Compared With Claims Data in Identifying Nursing Home Admissions With Mental Illness.
Article in Journal of the American Medical Directors Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectivesNursing homes (NHs) are an important setting of care for individuals with complex mental health conditions, including schizophrenia, bipolar disorder, and other (nonschizophrenia) psychoses [ie, serious mental illness (SMI)]. The federally mandated Preadmission Screening and Resident Review (PASRR) program is in place to help ensure that individuals identified as having SMI, among other conditions, are appropriately admitted to an NH rather than a less restrictive community setting. However, it is unclear the extent to which the PASRR SMI flag aligns with diagnoses recorded by clinicians in claims/encounter data.
designCross-sectional study design. SETTING AND
participantsOne hundred percent of 2022 Minimum Data Set admission assessments linked to Medicare (including traditional Medicare and Medicare Advantage) and Medicaid inpatient and outpatient administrative claims to examine the overlap between PASRR priority categories and SMI as derived from complementary resident claims/encounter diagnoses.
methodsDescriptive (χ
resultsOf roughly 1.9 million new admissions in 2022, 2.4% had a PASRR SMI flag, whereas 12.3% had an administratively data-derived SMI diagnosis. Among the 234,519 admissions with a claims/encounter-derived SMI diagnosis, 11.3% had a PASRR:SMI flag. CONCLUSIONS AND IMPLICATIONS: Federally mandated PASRR screening assessments appropriately identify roughly 1 in every 10 admissions with a claims/encounter-derived SMI diagnosis, raising substantial concerns over whether the program can effectively facilitate appropriate NH placement, as originally intended. Forty years after the Omnibus Budget Reconciliation Act of 1987, our findings raise questions about the continued utility of this federal screening program and suggest that more substantive revisions may be necessary to meet the needs of the increasingly complex and multifaceted population of patients who enter NHs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.